- Home
- NPWR vs BIOA Comparison
NPWR vs BIOA Comparison
Compare NPWR & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPWR
- BIOA
- Stock Information
- Founded
- NPWR 2010
- BIOA 2015
- Country
- NPWR United States
- BIOA United States
- Employees
- NPWR N/A
- BIOA N/A
- Industry
- NPWR Industrial Machinery/Components
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- NPWR Energy
- BIOA Health Care
- Exchange
- NPWR Nasdaq
- BIOA Nasdaq
- Market Cap
- NPWR 148.7M
- BIOA 167.8M
- IPO Year
- NPWR N/A
- BIOA 2024
- Fundamental
- Price
- NPWR $2.62
- BIOA $4.12
- Analyst Decision
- NPWR Buy
- BIOA Hold
- Analyst Count
- NPWR 2
- BIOA 4
- Target Price
- NPWR $4.00
- BIOA $5.67
- AVG Volume (30 Days)
- NPWR 2.0M
- BIOA 111.2K
- Earning Date
- NPWR 08-11-2025
- BIOA 08-15-2025
- Dividend Yield
- NPWR N/A
- BIOA N/A
- EPS Growth
- NPWR N/A
- BIOA N/A
- EPS
- NPWR N/A
- BIOA N/A
- Revenue
- NPWR $250,000.00
- BIOA $1,451,000.00
- Revenue This Year
- NPWR $308.00
- BIOA N/A
- Revenue Next Year
- NPWR $1,811.08
- BIOA N/A
- P/E Ratio
- NPWR N/A
- BIOA N/A
- Revenue Growth
- NPWR 100.00
- BIOA N/A
- 52 Week Low
- NPWR $1.48
- BIOA $2.88
- 52 Week High
- NPWR $14.28
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- NPWR 45.46
- BIOA N/A
- Support Level
- NPWR $2.68
- BIOA N/A
- Resistance Level
- NPWR $3.41
- BIOA N/A
- Average True Range (ATR)
- NPWR 0.28
- BIOA 0.00
- MACD
- NPWR -0.04
- BIOA 0.00
- Stochastic Oscillator
- NPWR 3.42
- BIOA 0.00
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.